Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness and Safety of Prothrombin Complex Concentrate (PCC) in Reversal of Direct FXa Inhibitor-Associated Bleeding and Perioperative Management
TCTR20250416010Recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Single-arm trial of prothrombin complex concentrate, human in Direct factor Xa inhibitor use, sponsored by Phramongkutklao Hospital. Started Feb 2025; status: recruiting.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
Direct factor Xa inhibitor use
Beyond the preview
Go deeper on TCTR20250416010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250416010.